Fractyl Health (GUTS) Operating Leases (2023 - 2026)
Fractyl Health (GUTS) reported Operating Leases of $25.5 million for Q1 2026, down 5.58% year-on-year from $27.0 million in Q1 2025, and down 1.6% quarter-over-quarter from $26.0 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Operating Leases data on file, last reported at $25.5 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 5.58% year-over-year to $25.5 million; the trailing twelve-month figure through Mar 2026 stood at $25.5 million (down 5.58% YoY), and the FY2025 full-year result was $26.0 million, down 5.21% from the prior year.
- Operating Leases for Q1 2026 stood at $25.5 million, down from $26.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $28.5 million in Q4 2023 and bottomed at $25.5 million in Q1 2026.
- A 4-year average of $27.1 million and a median of $27.2 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases decreased 3.95% in 2024 and decreased 5.58% in 2026, its largest moves.
- Tracing GUTS's Operating Leases over 4 years: stood at $28.5 million in 2023, then declined by 3.95% to $27.4 million in 2024, then fell by 5.21% to $26.0 million in 2025, then fell by 1.6% to $25.5 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $25.5 million, $26.0 million, and $26.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.54 Mn |
| Dec 31, 2025 | 25.96 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Jun 30, 2025 | 26.70 Mn |
| Mar 31, 2025 | 27.05 Mn |
| Dec 31, 2024 | 27.38 Mn |
| Sep 30, 2024 | 27.69 Mn |
| Jun 30, 2024 | 27.97 Mn |
| Mar 31, 2024 | 28.25 Mn |
| Dec 31, 2023 | 28.51 Mn |